Blue Bird Corp (BLBD) CFO exercises options and sells 7,006 shares

Q: What insider transaction did Blue Bird Corp (BLBD) report in this Form 4?

The Chief Financial Officer exercised stock options for 7,006 shares of common stock at $12.35 per share and sold 7,006 shares at a weighted average price of $51.58 on December 17, 2025 .

Q: At what prices did the Blue Bird Corp (BLBD) insider sell shares?

The sale of 7,006 shares of Blue Bird common stock was executed at a weighted average price of $51.58 per share, with individual sale prices ranging from $51.55 to $51.64 on December 17, 2025 .

Q: Were the Blue Bird Corp (BLBD) insider sales made under a Rule 10b5-1 plan?

Yes. The sales on December 17, 2025 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025 .

Q: What stock options did the Blue Bird Corp (BLBD) CFO exercise?

The CFO exercised stock options (right to buy) for 3,503 shares twice, totaling 7,006 shares , at an exercise price of $12.35 per share, with the final tranche vesting on December 12, 2025 .

Q: What type of security was involved in the Blue Bird Corp (BLBD) insider transaction?

The transactions involved common stock, par value $0.0001 per share, and related stock options (right to buy) that were exercised and then partially sold as reported.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Blue Bird Corporation’s Chief Financial Officer reported an options exercise and share sale. On December 17, 2025, the officer exercised stock options to acquire a total of 7,006 shares of common stock at an exercise price of $12.35 per share, through two transactions of 3,503 shares each. That same day, 7,006 shares of common stock were sold at a weighted average price of $51.58 per share under a pre-arranged Rule 10b5-1 trading plan, with sale prices ranging from $51.55 to $51.64. After these transactions, the officer directly beneficially owned 46,180 shares of Blue Bird common stock.

Insider Trade Summary

Net Seller: 7,006 shares ($361,369)

Net Sell 5 txns

Insider Radulescu Razvan

Role Chief Financial Officer

Sold 7,006 shs ($361K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	3,503	$0.00	--
Exercise	Stock Option (right to buy)	3,503	$0.00	--
Exercise	Common Stock, par value $0.0001	3,503	$12.35	$43K
Exercise	Common Stock, par value $0.0001	3,503	$12.35	$43K
Sale	Common Stock, par value $0.0001	7,006	$51.58	$361K

Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct); Common Stock, par value $0.0001 — 49,683 shares (Direct)

Footnotes (1)

The price reported in Column 4 is a weighted average price resulting from shares sold in multiple transactions on December 17, 2025, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025, at prices ranging from $51.55 to $51.64, inclusive. The reporting person undertakes to provide to Blue Bird Corporation, any security holder of Blue Bird Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The final tranche of the stock option's three tranches vested on December 12, 2025.

Form 4 Insider Transactions: What Each Field Means →

12/17/2025 - 03:50 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Radulescu Razvan

(Last)

(First)

(Middle)

3920 ARKWRIGHT ROAD

SUITE 200

(Street)

MACON

31210

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Blue Bird Corp [ BLBD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.0001	12/17/2025		M		3,503	A	$12.35	49,683	D
Common Stock, par value $0.0001	12/17/2025		M		3,503	A	$12.35	53,186	D
Common Stock, par value $0.0001	12/17/2025		S		7,006	D	$51.58⁽¹⁾	46,180	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$12.35	12/17/2025		M			3,503	12/12/2025	12/12/2032	Common Stock, par value $0.0001	3,503	$0	0	D
Stock Option (right to buy)	$12.35	12/17/2025		M			3,503	⁽²⁾	12/12/2032	Common Stock, par value $0.0001	3,503	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price resulting from shares sold in multiple transactions on December 17, 2025, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025, at prices ranging from $51.55 to $51.64, inclusive. The reporting person undertakes to provide to Blue Bird Corporation, any security holder of Blue Bird Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The final tranche of the stock option's three tranches vested on December 12, 2025.

Remarks:

	/s/ Matthew Meziere as attorney-in-fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Blue Bird Corp (BLBD) report in this Form 4?

The Chief Financial Officer exercised stock options for 7,006 shares of common stock at $12.35 per share and sold 7,006 shares at a weighted average price of $51.58 on December 17, 2025.

How many Blue Bird Corp (BLBD) shares does the CFO own after this transaction?

Following the reported transactions, the Chief Financial Officer directly beneficially owned 46,180 shares of Blue Bird Corporation common stock.

At what prices did the Blue Bird Corp (BLBD) insider sell shares?

The sale of 7,006 shares of Blue Bird common stock was executed at a weighted average price of $51.58 per share, with individual sale prices ranging from $51.55 to $51.64 on December 17, 2025.

Were the Blue Bird Corp (BLBD) insider sales made under a Rule 10b5-1 plan?

Yes. The sales on December 17, 2025 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025.

What stock options did the Blue Bird Corp (BLBD) CFO exercise?

The CFO exercised stock options (right to buy) for 3,503 shares twice, totaling 7,006 shares, at an exercise price of $12.35 per share, with the final tranche vesting on December 12, 2025.

What type of security was involved in the Blue Bird Corp (BLBD) insider transaction?

The transactions involved common stock, par value $0.0001 per share, and related stock options (right to buy) that were exercised and then partially sold as reported.